Zinc, selenium and chromium co-supplementation improves insulin resistance by preventing hepatic endoplasmic reticulum stress in diet-induced gestational diabetes rats

J Nutr Biochem. 2021 Oct:96:108810. doi: 10.1016/j.jnutbio.2021.108810. Epub 2021 Jun 27.

Abstract

Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications and results in adverse outcomes for pregnant women and their offspring. Endoplasmic reticulum (ER) stress is associated with insulin resistance and implicates in the development of GDM. Zinc, selenium and chromium have been shown to maintain glucose homeostasis via multiple mechanisms, but how these trace elements affect the insulin resistance and ER stress in GDM are largely unknown. To address this, a GDM rat model was induced by feeding female Sprague-Dawley rats a high-fat (45%) and sucrose diet, while zinc (10 mg/kg.bw), selenium (20 ug/kg.bw), chromium (20 ug/kg.bw) were daily supplemented alone or in combination from 6 weeks before mating to the end of lactation period. Maternal metabolic parameters, hepatic ER stress and insulin signaling were analyzed. The results showed that zinc, selenium and chromium co-supplementation dramatically alleviated high-fat and sucrose-induced glucose intolerance and oxidative stress during entire experiment period. Hepatic ER stress as well as the unfolded protein response was activated in GDM dams, characterized by the up-regulation of glucose-regulated protein 78, phosphorylated the protein kinase RNA-like endoplasmic reticulum kinase, and the inositol-requiring enzyme 1α. Zinc, selenium and chromium supplementation significantly prevented this activation, by which contributes to the promotion of the phosphorylated protein kinase B related insulin signaling and maintenance of glucose homeostasis. In conclusion, zinc, selenium and chromium supplementation may be a promising way to prevent the development of GDM by alleviating hepatic ER stress.

Keywords: Chromium; Endoplasmic reticulum stress; Gestational diabetes mellitus; Insulin resistance; Selenium; Zinc.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromium / therapeutic use*
  • Diabetes, Gestational / drug therapy*
  • Diabetes, Gestational / etiology
  • Diabetes, Gestational / metabolism
  • Endoplasmic Reticulum Stress / drug effects*
  • Female
  • Insulin Resistance*
  • Liver / drug effects
  • Liver / metabolism
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Selenium / therapeutic use*
  • Zinc / therapeutic use*

Substances

  • Chromium
  • Selenium
  • Zinc